Cargando…

Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson’s Disease: Randomized Trial

Objective: Real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback (NF) uses feedback of the patient’s own brain activity to self-regulate brain networks which in turn could lead to a change in behavior and clinical symptoms. The objective was to determine the effect of NF and motor...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramanian, Leena, Morris, Monica Busse, Brosnan, Meadhbh, Turner, Duncan L., Morris, Huw R., Linden, David E. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896907/
https://www.ncbi.nlm.nih.gov/pubmed/27375451
http://dx.doi.org/10.3389/fnbeh.2016.00111
_version_ 1782436043987877888
author Subramanian, Leena
Morris, Monica Busse
Brosnan, Meadhbh
Turner, Duncan L.
Morris, Huw R.
Linden, David E. J.
author_facet Subramanian, Leena
Morris, Monica Busse
Brosnan, Meadhbh
Turner, Duncan L.
Morris, Huw R.
Linden, David E. J.
author_sort Subramanian, Leena
collection PubMed
description Objective: Real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback (NF) uses feedback of the patient’s own brain activity to self-regulate brain networks which in turn could lead to a change in behavior and clinical symptoms. The objective was to determine the effect of NF and motor training (MOT) alone on motor and non-motor functions in Parkinson’s Disease (PD) in a 10-week small Phase I randomized controlled trial. Methods: Thirty patients with Parkinson’s disease (PD; Hoehn and Yahr I-III) and no significant comorbidity took part in the trial with random allocation to two groups. Group 1 (NF: 15 patients) received rt-fMRI-NF with MOT. Group 2 (MOT: 15 patients) received MOT alone. The primary outcome measure was the Movement Disorder Society—Unified PD Rating Scale-Motor scale (MDS-UPDRS-MS), administered pre- and post-intervention “off-medication”. The secondary outcome measures were the “on-medication” MDS-UPDRS, the PD Questionnaire-39, and quantitative motor assessments after 4 and 10 weeks. Results: Patients in the NF group were able to upregulate activity in the supplementary motor area (SMA) by using motor imagery. They improved by an average of 4.5 points on the MDS-UPDRS-MS in the “off-medication” state (95% confidence interval: −2.5 to −6.6), whereas the MOT group improved only by 1.9 points (95% confidence interval +3.2 to −6.8). The improvement in the intervention group meets the minimal clinically important difference which is also on par with other non-invasive therapies such as repetitive Transcranial Magnetic Stimulation (rTMS). However, the improvement did not differ significantly between the groups. No adverse events were reported in either group. Interpretation: This Phase I study suggests that NF combined with MOT is safe and improves motor symptoms immediately after treatment, but larger trials are needed to explore its superiority over active control conditions.
format Online
Article
Text
id pubmed-4896907
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-48969072016-07-01 Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson’s Disease: Randomized Trial Subramanian, Leena Morris, Monica Busse Brosnan, Meadhbh Turner, Duncan L. Morris, Huw R. Linden, David E. J. Front Behav Neurosci Neuroscience Objective: Real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback (NF) uses feedback of the patient’s own brain activity to self-regulate brain networks which in turn could lead to a change in behavior and clinical symptoms. The objective was to determine the effect of NF and motor training (MOT) alone on motor and non-motor functions in Parkinson’s Disease (PD) in a 10-week small Phase I randomized controlled trial. Methods: Thirty patients with Parkinson’s disease (PD; Hoehn and Yahr I-III) and no significant comorbidity took part in the trial with random allocation to two groups. Group 1 (NF: 15 patients) received rt-fMRI-NF with MOT. Group 2 (MOT: 15 patients) received MOT alone. The primary outcome measure was the Movement Disorder Society—Unified PD Rating Scale-Motor scale (MDS-UPDRS-MS), administered pre- and post-intervention “off-medication”. The secondary outcome measures were the “on-medication” MDS-UPDRS, the PD Questionnaire-39, and quantitative motor assessments after 4 and 10 weeks. Results: Patients in the NF group were able to upregulate activity in the supplementary motor area (SMA) by using motor imagery. They improved by an average of 4.5 points on the MDS-UPDRS-MS in the “off-medication” state (95% confidence interval: −2.5 to −6.6), whereas the MOT group improved only by 1.9 points (95% confidence interval +3.2 to −6.8). The improvement in the intervention group meets the minimal clinically important difference which is also on par with other non-invasive therapies such as repetitive Transcranial Magnetic Stimulation (rTMS). However, the improvement did not differ significantly between the groups. No adverse events were reported in either group. Interpretation: This Phase I study suggests that NF combined with MOT is safe and improves motor symptoms immediately after treatment, but larger trials are needed to explore its superiority over active control conditions. Frontiers Media S.A. 2016-06-08 /pmc/articles/PMC4896907/ /pubmed/27375451 http://dx.doi.org/10.3389/fnbeh.2016.00111 Text en Copyright © 2016 Subramanian, Morris, Brosnan, Turner, Morris and Linden. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Subramanian, Leena
Morris, Monica Busse
Brosnan, Meadhbh
Turner, Duncan L.
Morris, Huw R.
Linden, David E. J.
Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson’s Disease: Randomized Trial
title Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson’s Disease: Randomized Trial
title_full Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson’s Disease: Randomized Trial
title_fullStr Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson’s Disease: Randomized Trial
title_full_unstemmed Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson’s Disease: Randomized Trial
title_short Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson’s Disease: Randomized Trial
title_sort functional magnetic resonance imaging neurofeedback-guided motor imagery training and motor training for parkinson’s disease: randomized trial
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896907/
https://www.ncbi.nlm.nih.gov/pubmed/27375451
http://dx.doi.org/10.3389/fnbeh.2016.00111
work_keys_str_mv AT subramanianleena functionalmagneticresonanceimagingneurofeedbackguidedmotorimagerytrainingandmotortrainingforparkinsonsdiseaserandomizedtrial
AT morrismonicabusse functionalmagneticresonanceimagingneurofeedbackguidedmotorimagerytrainingandmotortrainingforparkinsonsdiseaserandomizedtrial
AT brosnanmeadhbh functionalmagneticresonanceimagingneurofeedbackguidedmotorimagerytrainingandmotortrainingforparkinsonsdiseaserandomizedtrial
AT turnerduncanl functionalmagneticresonanceimagingneurofeedbackguidedmotorimagerytrainingandmotortrainingforparkinsonsdiseaserandomizedtrial
AT morrishuwr functionalmagneticresonanceimagingneurofeedbackguidedmotorimagerytrainingandmotortrainingforparkinsonsdiseaserandomizedtrial
AT lindendavidej functionalmagneticresonanceimagingneurofeedbackguidedmotorimagerytrainingandmotortrainingforparkinsonsdiseaserandomizedtrial